Cancer drug Gleevec holds promise for type 2 diabetes

Stephen FellerULSAN, South Korea, March 28 (UPI) -- The cancer drug Gleevec lowered the level of insulin resistance in mice in a study, and lowered risk of hyperglycemia and obesity, without severe side effects.

Source: Health News - UPI.com - March 28, 2016 Category: Consumer Health News Source Type: news